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Abstract
Mouse embryonic stem cells (mESC) have been used to study lineage specification in vitro, including towards a hepatocyte-
like fate, and such investigations guided lineage differentiation protocols for human (h)ESC. We recently described a four-
step protocol to induce hepatocyte-like cells from hESC which also induced hepatocyte-like cell differentiation of mouse
induced pluripotent stem cells. As ESC also spontaneously generate hepatocyte-like cells, we here tested whether the
growth factors and serum used in this protocol are required to commit mESC and hESC to hepatocyte-like cells. Culture of
mESC from two different mouse strains in the absence of serum and growth factors did not induce primitive streak/
definitive endoderm genes but induced default differentiation to neuroectoderm on day 6. Although Activin-A and Wnt3
induced primitive streak/definitive endoderm transcripts most robustly in mESC, simple addition of serum also induced
these transcripts. Expression of hepatoblast genes occurred earlier when growth factors were used for mESC differentiation.
However, further maturation towards functional hepatocyte-like cells was similar in mESC progeny from cultures with
serum, irrespective of the addition of growth factors, and irrespective of the mouse strain. This is in contrast to hESC, where
growth factors are required for specification towards functional hepatocyte-like cells. Culture of mESC with serum but
without growth factors did not induce preferential differentiation towards primitive endoderm or neuroectoderm. Thus,
although induction of primitive streak/definitive endoderm specific genes and proteins is more robust when mESC are
exposed to a combination of serum and exogenous growth factors, ultimate generation of hepatocyte-like cells from mESC
occurs equally well in the presence or absence of exogenous growth factors. The latter is in contrast to what we observed
for hESC. These results suggest that differences exist between lineage specific differentiation potential of mESC and hESC,
requiring optimization of different protocols for ESC from either species.
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Introduction
Development of the mammalian liver is the result of a multistep
process, requiring different growth factors at the correct
concentrations, location and time, aside from specific cell-cell
and cell-extracellular matrix interactions [1]. Understanding these
molecular signals favouring liver development is thought to be
essential to develop in vitro differentiation protocols to induce a
hepatic fate in ESC. Although ESC from human and murine
origin are pluripotent, it is becoming clear that species differences,
and likely also genetic differences within a given species, influence
the culture requirements as well as the efficiency of lineage
differentiation of different ESC lines.
Liver development can be divided in 4 consecutive steps:
gastrulation of the epiblast with the formation of first primitive
streak (PS) and then definitive endoderm (DE); specification of DE
into foregut, midgut and hindgut endoderm [2,3]; subsequent
specification of the ventral foregut endoderm towards a hepatic
cell fate [4]; and finally, outgrowth of the liver bud and terminal
differentiation of hepatoblasts into either hepatocytes or cholan-
giocytes [1,5] (Figure 1). Based on this knowledge, we recently
described a 4-step differentiation protocol that supports the
differentiation of hESC lines [6] towards DE and functional
hepatocyte-like cells.
To differentiate mESC to hepatocytes, some groups have used
in the initial step of differentiation embryoid body cultures,
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genes of different lineages, including definitive endoderm, but
also primitive endoderm (PrE) [7]. Multiple studies have used
sequential addition of growth factors in 2D cultures, as in the
protocol described by us for hESC [6], to differentiate ESC
towards hepatocyte-like cells [8,9,10]. However, most studies did
not assess whether the growth factors added enhance the
induction towards liver fate above the normal spontaneous ability
of mESC to generate endoderm and cells with hepatocyte
features. In addition, few if any study directly compared the
ability of a given protocol to induce hepatic differentiation from
mESC as well as hESC, or mESC from different genetic
background.
Here, we tested if the different cytokine cocktails used
sequentially to induce hESC to cells with hepatocyte-like features
are required to induce hepatocyte-like cells from mESC
originating from C57Bl/6 and 129 mice.
Results
Serum or Activin-A/Wnt3a is sufficient to induce
primitive streak and definitive endoderm from mESC
In the absence of serum or growth factors minimal induction of
PS/DE genes was observed by day 6. Moreover, the absence of
both serum and growth factors resulted in massive cell death by
day 10. However, the addition of serum alone (3 different batches),
Activin-A and Wnt3a alone, or a combination of all induced a
significant increase in the expression of the PS/DE genes (Mixl1,
Gsc, Cxcr4, Brachyury and Eomes) by day 6 in both mESC lines from
129 and C57Bl/6 mice. The highest level of gene induction was
seen when cells were cultured with the combination of serum plus
Activin-A/Wnt3a, followed by Activin-A/Wnt3a alone, and then
serum alone (Figure 2A). Noteworthy, expression levels of PS/DE
genes decreased following day 6 in both cell lines, whether the cells
were treated with Activin-A and Wnt3a or not (Table S1). No
significant differences were seen in expression levels of the
pluripotency gene Oct4 between the different treated groups.
These results are consistent with the notion that TGF-b family
members and Wnt’s are present in serum [11] at levels sufficient to
induce PS/DE genes. In addition, serum may contain additional
factors that enhance the effect of Activin-A/Wnt3a on PS/DE
induction. Consistent with the highest expression of PS/DE genes
by RT-qPCR, Mixl1
+Oct4
2 cells could only be identified by
immunohistochemistry on day 6 in mESC progeny treated with
both serum and Activin-A/Wnt3a (Figure 3A).
In contrast to the findings in mESC, when hESC were cultured
with serum but without Activin-A/Wnt3a minimal to no induction
of PS/DE specific transcripts were seen on day 6, while these
transcripts were induced significantly in the presence of the two
cytokines (Figure 4).
Serum or Activin-A/Wnt3a is sufficient to prevent default
differentiation of mESC to neuroectoderm and primitive
endoderm
Default differentiation of mESC to neuroectoderm occurs when
culturing mESC in serum-free medium and in the absence of any
growth factors [12,13]. We demonstrated that Sox1 was signifi-
cantly up-regulated when differentiations were initiated in the
absence of serum while presence of serum or growth factors
prevented induction of Sox1 expression in mESC (Figure 2B). Of
note, levels of Otx2 were significantly increased in both mESC cell
lines cultured with serum and Activin-A/Wnt3a (n=3, p,0.05),
most likely reflecting the important role of Otx2 during
gastrulation, rather than neural differentiation [14,15].
Previous studies have also shown a preferential differentiation
of mESC towards primitive and visceral endoderm (PrE/VE)
(Thbd, Sox7, Tmprss2, Hnf4a, Ttr, Afp) when mESC are cultured in
2D without Activin-A [16,17]. However, on day 6, expression
levels for Thbd and Tmprss2 were identical in mESC-progeny
cultured with or without Activin-A/Wnt3a in the presence of
serum. Sox7 levels were identical or even higher in the Activin-A/
Figure 1. Overview of liver embryogenesis. Growth factors used to mimic different developmental step are indicated in red.
doi:10.1371/journal.pone.0023096.g001
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(Table S1).
Addition of sequential cytokine cocktails does not affect
final expression levels of mature hepatic genes in mESC
progeny
In both mESC cell lines, Sox17, Afp, Ttr, Foxa2 and Hnf4a (genes
expressed in hepatic endoderm) increased significantly already
from day 6 onwards when differentiation was induced with a
combination of growth factors and serum (n.3), whereas
induction of these genes did not occur until day 12 in the no-
cytokine condition (n=3) (Figure 2C). However, by day 28,
expression levels of these genes were similar in mESC progeny
irrespective of the addition of growth factors, with the exception of
Hnf4a (n=3). During further differentiation, a progressive increase
in expression of transcripts for Alb, Aat, Tat, G6p, Pepck, Cyp7a1 and
Cyp1a2 was observed in both cell lines irrespective of whether
growth factors were added or not (n=3) (Figure 2D, Table S1).
Again in contrast to mESC, the final progeny of hESC-derived
hepatocyte-like cells’ expression of hepatoblast and more mature
hepatocyte-genes was significantly higher in cells differentiated in
the presence of growth factors, compared with cells treated with
serum alone (Figure 4).
Growth factors do not affect expression of liver-specific
non-parenchymal genes and other mesodermal genes in
mESC progeny
Because the liver not only consists of hepatocytes, we tested
whether mESC also generate cells with features of hepatic
sinusoidal endothelial cells (Lyve1, Stab2, Vap1, CD32b, Mrc1,
Tie2, Ve-cadherin) and hepatic stellate cells (Alcam, Col1a1, Desmin,
Gfap, aSma, Gpr91, Crbp1) [18,19]. A significant increase in Tie2,
Ve-cadherin and Lyve1 transcripts was seen during differentiation
(,2
5–10 times increase), irrespective of cytokine addition. Upon
differentiation of both cell lines, expression of Alcam, Col1a1,
Desmin, Gfap, aSma and Crbp1 was significantly up-regulated by day
28 as compared to day 0 (p,0.05), but again irrespective of
cytokine addition. We also assessed the expression of other
mesodermal genes (Cnn1, Sm22, Nkx2-5, Mesp2, Osterix), but these
were not induced whether or not growth factors were added
(Table S1).
Minimal differences in expression of cytokine transcripts
between mESC cultured with or without growth factors
Because we observed only minimal differences between
differentiations done with or without addition of exogenous
growth factors, we determined if the growth factors added
Figure 2. Gene expression in mESC-R1 during different stages of mesendoderm and hepatic specification during the 20 day
differentiation process (n=3). Relative expression values on day 6 compared to day 0 of mesendodermal [A] and neurectodermal genes [B] in the
different conditions. Time-dependent gene expression of hepatic endoderm specific genes [C] and relative expression values on day 20 compared to
day 0 of hepatocyte-specific genes [D]. *p,0.05 serum+growth factors versus serum only.
doi:10.1371/journal.pone.0023096.g002
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mESC themselves. To induce PS/DE, a combination of Activin-A
and Wnt3a is used. Fgf8 is a known downstream target of Wnt
signalling and its induction is required for PS formation and
migration of cells into the PS [20], whereas Foxh1 combined with
Smad2/3/4 are important for the amplification of Nodal
expression before and during gastrulation [21]. Fgf8 was more
induced at day 6 in the presence of Activin-A and Wnt3a
compared with serum alone, consistent with the observation that
the PS/DE genes were most robustly expressed in this condition.
Nodal, already highly expressed in undifferentiated mESC,
persisted longer in the presence of Activin-A and Wnt3a in
mESC, but levels of Foxh1 were identical in both conditions. In
undifferentiated hESC, the levels of NODAL were lower compared
to undifferentiated mESC (relative expression 0.2% of GAPDH in
hESC versus 5.8% of Gapdh in mESC), but were induced to levels
similar to those found in mESC on day 6 when Activin-A/Wnt3a
were used to induce differentiation from hESC. We also assessed
the expression of the different Fgf’s, Bmp4 and Hgf, growth factors
added in steps 2–4, which were expressed to a similar degree in
both conditions tested and in both mESC lines (Table S1).
Growth factors increase the number of Hnf4a
+ cells in
mESC progeny significantly
As no major differences were observed between the 2 mESC
lines, we performed immunochemistry and functional assays
o n l yo nt h eR 1c e l ll i n e( n $3). By day 28, Alb
2Hnf4a
+
(endoderm, mostly likely hepatic endoderm) and Alb
+Hnf4a
+
cells (hepatoblasts/hepatocytes) could be detected whether or
not growth factors were used during differentiation (Figure 3B).
Consistent with the RT-qPCR results, a significantly higher
number of Hnf4a
+ cells could be observed when differentiations
were done with growth factors (60.5612.0% versus
17.1614.7% no growth factors, p,0.0001). Similarly a small
but significant increased number of Alb
+ cells was detected
when differentiations were performed under guidance of growth
factors (5.362.4% of total cells versus 2.763.2% no growth
factors, p,0.01). Compared to serum-only condition, the
addition of growth factors increased the number of Hnf4a
+
cells by 3.5-fold, while the number of Alb
+ cells was only
increased by 2-fold. This suggests that the addition of growth
factors during mESC differentiation enhances (hepatic) endo-
derm formation to a greater extent than hepatocyte maturation.
Final mESC progeny has similar hepatic function
irrespective of cytokine addition
Consistent with the similar levels of Alb transcripts during
differentiation and the presence of 5.2 and 2.4% Alb
+ cells in
progeny of mESC cultured with or without growth factors,
respectively, similar amounts of albumin were secreted in the
culture supernatants at day 28 of mESC progeny differentiated
with or without growth factors (Figure 5A). Likewise, accumula-
tion of glycogen, urea production (and increase after NH4HCO3)
and Cyp1a2 function was detected and similar in both conditions
(Figure 5B–D). The functional capacity of either progeny was
between 0.24% and 5.8% of mature mouse hepatocytes.
Consistent with the lower mature hepatocyte transcript
expression found in hESC differentiated without addition of
growth factors compared with hESC differentiated with growth
factors, differences could also be noticed at the functional level.
Albumin secretion, accumulation of glycogen, urea production
(and increase after exposure to NH4HCO3) and CYP3A4 function
Figure 3. Immunofluorescence assessment mESC progeny (n=3). [A] Presence of Oct42/Mixl1+ cells on day 6, only in the presence of
additional growth factors. In the condition without growth factors, no Oct42/Mixl1+ cells could be observed (data not shown). [B] Presence of
Hnf4a+/Alb+ cells on day 20, was significantly higher in the condition with additional growth factors, as quantified in the pie-charts.
doi:10.1371/journal.pone.0023096.g003
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supplemented differentiations than progeny of hESC allowed to
differentiate without addition of growth factors (Figure 5A–D).
Discussion
Understanding the mechanisms that regulate hepatic epithelial
cell differentiation are thought to be essential for the creation of
efficient, programmed hepatic differentiation protocols from plurip-
otent stem cells. We here demonstrate that differences in response of
pluripotent stem cells to cytokine-mediated lineage specification and
differentiation between species will need to be taken into account,
when inducing hepatic differentiation from ESC.
During development of the mammalian liver, posterior epiblast
cells from the blastocyst at first undergo a process called
gastrulation, which results in the formation of mesendoderm
(ME), followed by DE and mesoderm. DE gives rise to the foregut,
midgut and hindgut endoderm. The liver develops from the
foregut endoderm, in response to factors secreted by the adjacent
cardiac mesoderm (Fgf1/2) and the septum transversum mesen-
chyme (Bmp2/4). The foregut endoderm forms the liver bud,
which contains bipotential hepatoblasts. Proliferation of the newly
specified early hepatoblasts can be increased by other FGF’s [5].
Induction of DE from mESC was initially described by
embryoid body formation either alone or combined with growth
factors mimicking development [22,23,24]. More recently many
groups have used monolayer cultures to induce DE and
subsequently hepatic endoderm in mESC [16,17,25]. These
studies have demonstrated the importance of initial cell density,
presence of serum, and the presence of Activin-A (.10–50 ng/
ml), for PS/DE induction [16,17,23]. In addition, DE commit-
ment from mESC and hESC in monolayer cultures appears to be
enhanced by an inhibitor of GSK-3b or by Wnt3a conditioned
medium [26].
We described a protocol that supports directed differentiation of
hESC in monolayer culture supplemented with 2% FCS to
hepatocyte-like cells by sequential induction of PS/DE by Activin-
A and Wnt3a, definitive and hepatic endoderm by BMP4 and
FGF’s, and hepatocyte-like cells with HGF and Follistatin
(Figure 1) [6]. Using the same hepatic differentiation protocol,
but extending step 4 to 28 days, we here demonstrate that mESC
cells from 129 and C57Bl/6 mice can be differentiated towards
functional hepatocyte-like cells. Genes, characteristic for PS/DE
were maximally and transiently expressed in response to Activin-A
and Wnt3a on day 6, followed by formation of hepatic endoderm
and finally gradual hepatic maturation. Hepatic maturation was
similar in both mESC lines. The results of the functional assays
(0.24 to 5.8% of primary hepatocytes activity) were comparable
with the functional results obtained when applying the protocol to
human ESC [6].
However, although the exogenous addition of growth factors
greatly improves PS/DE formation, as well as final hepatic
Figure 4. Comparison of gene expression between hESC-H9 and mESC-R1 progeny (n=3, *p,0.05, NS=not significant). Gene
expression of mesendodermal and hepatocyte-specific genes during hESC and mESC differentiation.
doi:10.1371/journal.pone.0023096.g004
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cultured with serum but without supplementation of growth
factors, differentiate to hepatocyte-like cells, with functional
properties comparable to those obtained when differentiation
was guided by growth factors. However, induction of transcripts of
PS/DE stage cells was significantly higher in the cultures
containing Activin-A and Wnt3a as was the expression of hepatic
endoderm genes, suggesting that exogenous addition of growth
factors enhances and accelerates the formation of hepatic
endoderm. This notion is strengthened by the higher number of
Mixl1
+/Oct4
2 cells found on d6, and the percent Hnf4a
+ cells on
d28 in cytokine treated mESC progeny.
The finding that simple addition of serum leads to PS/DE gene
expression is consistent with the notion that TGF-b family
members and Wnt’s are present in serum, apparently at levels
sufficient to induce PS/DE genes in mESC. One difference
between mESC and hESC is the expression levels of Nodal/
NODAL and Foxh1/FOXH1, which are significantly higher
expressed in mESC than hESC. As Nodal is the in vivo counterpart
of Activin, endogenously produced Nodal may support the PS/DE
induction in mESC progeny cultured without exogenous Activin-
A. It is worth noting that the combination of growth factors and
serum induced PS/DE genes most robustly, suggesting that
additional factors in serum, other than TGF-b members and
Wnt’s, may play a role in for PS/DE induction. ‘Spontaneous’
maturation of hepatic endoderm and hepatoblasts once the cells go
through the PS/DE, may be the result of endogenous production
of growth factors as assessed by RT-qPCR (Bmp4, Fgf2, Fgf4, Fgf8,
till d12, and low levels of Hgf from d12 onwards).
In contrast to previous studies [16,17,27], no preferential
differentiation of mESC to PrE was seen in the absence of Activin-
A and Wnt3a. Although some genes, typically expressed in PrE,
such as Sox7, Thbd and Tmprss2, became expressed to significant
higher levels compared to undifferentiated mESC at later time
points during differentiation (beyond day 12), this likely represents
differentiation towards other cell types, which also express these
genes, at later stages of development [28,29] (Table S1). The
reason for the differences found in PrE differentiation in the
absence of Activin-A and Wnt3a in our studies is not readily
explained, but may be caused by differences in cytokine content in
FCS used in our studies and those of others.
It should be noted that with or without growth factors, the final
differentiated progeny from mESC is still mixed. For instance, on
day 28 of differentiation, mature hepatic genes (Tat, Pepck, G6pc,
Figure 5. Functional characteristics of mESC and hESC progeny as well as primary hepatocytes at day 20 (n=3, *p,0.05, NS=not
significant). [A] Albumin secretion (ng/ml/48 hrs) [B] Storage of glycogen (nmol glucose/mg protein) [C] Urea production [D] Cytochrome P450
activity. In mESC progeny no significant differences were observed between the two conditions, while in the hESC progeny functional capacities were
significantly higher in the presence of additional growth factors.
doi:10.1371/journal.pone.0023096.g005
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hepatic genes such as Afp and Ttr. As we also found high level
expression of Krt19 and Krt7 at the end of differentiation, this
suggests persistent presence of a high percentage of hepatoblast-
like cells, consistent with the high number of Hnf4a
+ cells seen by
immunohistology. As seen in miPSC differentiation [30], we have
also suggestive evidence that cells with hepatic stellate cell and
endothelial features may co-differentiate during the differentiation
process. Other differentiation protocols may generate a higher
number of rather immature hepatocyte-like cells expressing Afp
and Ttr such as for instance by re-plating cells at definitive
endoderm stage [31]. However, the current protocol appears to
generate more mature hepatocyte-like cells, expressing e.g. Tat,
G6pc and Cyp1a2, as well as liver-specific non-parenchymal cells.
In conclusion, in contrast to hepatic differentiation from hESC
that is dependent on the stepwise addition of growth factors, no
significant effect on maturation of mESC-progeny was observed
when mESC were allowed to differentiate in the absence of
cytokine, but in serum-containing medium. These results suggest
that differences exist between lineage specific differentiation of
mESC and hESC, requiring optimization of different protocols for
ESC from either species.
Materials and Methods
Media Composition and Cytokines
Basal differentiation medium: 60% DMEM-low glucose (Gibco
31885), 40% MCDB-201-water (Sigma M-6770), 0.256 Linoleic
acid – Bovine serum albumin (LA-BSA, Sigma L-9530), 0.256
Insulin-transferrin-selenium (ITS, Sigma I-3146), 16 Penicillin-
Streptomycin (Cellgro 30-002-CI), 0.1 mM L-Ascorbic Acid
(Sigma A8960), 10
23 mM Dexamethasone (Sigma D2915),
110 mM 2-mercaptoethanol (Gibco 31350).
Mouse embryonic fibroblasts (MEFs) expansion medium: 90% DMEM
high glucose (Gibco 41965), 10% fetal bovine serum (FBS,
HyClone), 26 L-glutamine (Invitrogen 2503-032), 26 Penicillin-
Streptomycin, 26MEM NEAA (Invitrogen 11140-035), 110 mM
2-mercaptoethanol.
Mouse ESC expansion medium: 80% DMEM high glucose, 20%
FBS, 16 L-glutamine, 16 Penicillin-Streptomycin, 16 MEM
NEAA, 16 sodium pyruvate (Invitrogen 11360), 110 mM2 -
mercaptoethanol, 50 ml mLIF (Chemicon ESG-1107).
Cytokines: The following cytokines and growth factors (all from
R&D Systems) were added during differentiation: rh/m/rActivin-
A (338-AC), rhBMP4 (314-BP), rhFGF1 (232-FA), rhFGF2 (233-
FB), rhFGF4 (235-F4-025), rmFGF8b (423-F8-025), rmFollistatin-
288 (769-FS), rhHGF (294-HGN) and rmWnt3a (1324-WN).
Cell Line Isolation and Maintenance
Mouse embryonic fibroblasts: MEFs were purchased from Global
Stem Inc, Rockville, USA. MEFs were maintained in MEF
expansion medium and immortalized with 10 ng/ml Mitomycin
C (KYOWA Mitomycin 2 mg) at passage 6. Mitomycin-treated
MEFs were plated at a density of 35,000 cells/cm
2 on 0.1%
gelatine (Ultrapure water 0.1% gelatine, Chemicon ES-006-B)
coated 6 well plates (Corning 3516).
Murine embryonic stem cells: The R1 cell line, derived from strain
129, was a kind gift from Prof. P. Carmeliet (K.U.Leuven,
Belgium), the Bl6 cell line, derived from strain C57BL/6, was a
kind gift from Prof. M. Ko (National Institute of Aging, Baltimore,
MD). mESC were plated on mitomycin-treated MEFs in mESC
expansion medium, maintained in a 21% O2 –5 %C O 2 –3 7 uC
incubator and split 1:6–1:8 every 2–3 days by trypsinization with
0.25% trypsin with EDTA (Gibco 25200056).
Primary murine hepatocytes: The isolated mouse hepatocytes were a
kind gift from Prof. M. Ott (University of Hannover, Germany).
Human embryonic stem cells: The H9 cells (purchased from WiCell,
Madison, WI) were cultured as described previously [6]. The
differentiation, RT-qPCR and functional tests described previous-
ly [6], were currently repeated with removal of cytokines as the
only alteration.
Hepatic differentiation. All differentiations were done in 12
well plates (Corning 3513) coated with 2% Matrigel (BD 356231)
in a 21% O2 – 5.8% CO2 –3 7 uC incubator. Prior to starting the
hepatic differentiation, undifferentiated mESC were plated for one
passage on 0.1% gelatin without MEFs to minimize the
contamination with MEFs upon initiation of differentiation.
mESC were trypsinized (trypsin 0.25%, Gibco 25200) and re-
plated at a density of 12,500–25,000 cells/cm
2 in basal
differentiation medium, combined with the sequential cytokine
cocktails as described in Figure 1 for 28 days. In the serum
conditions 2% FBS was added for the first 2 days, but this was
reduced to 0.5% after 2 days. In the cytokine group, basal
differentiation medium was supplemented with 100 ng/ml
Activin-A and Wnt3a from d0–6, 10 ng/ml FGF2 and 50 ng/
ml BMP4 from d6–10, 25 ng/ml FGF8b, 50 ng/ml FGF1 and
10 ng/ml FGF4 from d10–14 and finally 20 ng/ml HGF and
100 ng/ml Follistatin till d28.
RNA isolation and RT-qPCR. Sequences of primers are
given in Table S2. As housekeeping gene glyceraldehydes-3-
phosphate dehydrogenase (Gapdh) was used. Qiagen RNeasy kit
was used for RNA isolation as per manufacturer’s instruction.
Results are expressed as DCT values with respect to Gapdh,
calculated as (CTgene –C T Gapdh), and thus the lower the number,
the higher the expression level. DCT values of .16 are considered
as not expressed. In the graphs, relative expression compared to
day 0 is depicted, calculated as 2‘(DCTday 0 – DCTday 6/28).
Immunohistochemistry. Primary and secondary antibodies
are given in Table S3. Cells were washed three times with PBS
and fixed with 10% neutral buffered formalin (Sigma) for
15 minutes at room temperature (RT). Cells were permeabilized
with PBST (0.2% Triton X-100 (Acros Organics) in PBS) for
30 minutes. Next, blocking was performed by incubated the cells
with 3% donkey serum (Jackson Labs, JACK017-000-121) in
PBST for 30 minutes at RT. After removal of the blocking buffer,
cells were incubated overnight at 4uC with the primary antibodies
in Dako antibody diluent (Dako S202230). After washing with
PBST, cells were incubated with fluorescence-labelled secondary
antibody and counterstained with Hoechst diluted in Dako diluent
for 2 hours at RT. Quantification of Hnf4a
+ and Alb
+ cells was
performed using Zeiss AxioVision Software version 4.8.1 on .15
randomly taken pictures.
Albumin secretion. On d26, differentiation medium was
completely removed and 1.5 ml of fresh medium was added per
well. After 48 hours, medium was collected and stored at 280uC
until further analysis. Mouse albumin was measured using a
quantitative ELISA kit (Starters kit Bethyl E101 and Bethyl E80–
129), following the manufacturer’s instructions.
Urea production. mESC progeny were washed with PBS
and cultured with 1 ml of differentiation medium containing 0 or
1m M N H 4HCO3 for 24 hours. Urea content was calculated
using QuantiChrom
TM Urea Assay Kit (BioAssay Systems DIUR-
500), as per manufacturer’s protocol.
Glycogen storage. Glycogen content was measured
according to the spectrophotometrical method of Seifter et al.
[32], as described for rMAPC previously [33]. mESC progeny
were scraped from the Matrigel coated wells and collected in
200 mlH 2O at day 28.
Hepatocytes from Mouse Embryonic Stem Cells
PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23096Cytochrome P450 activity. Cytochrome 1a2 activity was
detected by using the non-lytic method of P450-Glo
TM Assay
(Promega V8901 and V8771). Induction of Cyp1a2 was
performed by incubation 500 mM phenobarbital, as per
manufacturer’s protocol.
Supporting Information
Table S1 Gene expression during hepatic differentiation of
mESC R1 (Table S1a) and mESC Bl6 (Table S1b) in the presence
(+) or absence (2) of growth factors. Results are expressed as DCT
values 6 SD. * significant higher (p,0.05) expressed, n$3.
(DOC)
Table S2 Mouse (Table S2a) and human primers (Table S2b)
for RT-qPCR.
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Table S3 Primary and secondary antibodies for immunocyto-
chemistry.
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